Target intelligence / Profile preview

Ferritin heavy chain 1 pseudogene 20 (FTH1P20)

Target
FTH1P20
Molecular classification
Other (pseudogene/non-coding RNA)
01

Overview

Ferritin heavy chain 1 pseudogene 20 (FTH1P20) is one of many non-coding pseudogenes related to the ferritin heavy chain 1 (FTH1) gene[1][4][5]. Unlike its protein-coding ancestor FTH1, FTH1P20 does not produce a functional protein. Instead, like some other FTH1 pseudogenes, it may participate in the regulation of FTH1 gene expression by acting as a decoy for microRNAs (a process called competing endogenous RNA or ceRNA activity), thereby influencing iron metabolism-related pathways and possibly having a mild regulatory, tumor-suppressive effect in certain cancers[2][4][5]. Direct evidence of FTH1P20’s individual function remains limited, and most available research discusses the broader family of FTH1 pseudogenes as a group rather than FTH1P20 specifically. FTH1P20 is not considered a direct therapeutic target, nor does it encode a functional protein product[1][2][4][5]. - Pseudogenes like FTH1P20 were once thought to be functionless but are now recognized as possible regulators of gene expression, especially in cancer and cellular metabolism[4][5][6]. - Only certain FTH1 pseudogenes have been experimentally linked to regulatory roles (such as FTH1P11 and FTH1P16); specific studies on FTH1P20 are lacking[2][4]. - The listed pseudogene has no known drug interactions, mechanisms of action, or biomarker utility[1][2][4][5].

02

Mechanism of action

Not applicable (no direct protein, not a therapeutic target)

03

Biological functions

Regulation of parental gene expression (by acting as a competing endogenous RNA or ceRNA for microRNAs targeting FTH1)Participation in post-transcriptional regulatory networks
04

Disease associations

Potential tumor suppressor function as part of FTH1 gene:pseudogene network (evidence for certain FTH1 pseudogenes in prostate cancer)Probable involvement in cancer-related iron metabolism (based on general evidence for FTH1 pseudogenes)No evidence for direct disease causation

Beyond the preview

Go deeper on Ferritin heavy chain 1 pseudogene 20 (FTH1P20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferritin heavy chain 1 pseudogene 20 (FTH1P20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call